CDC sees “no indication of a broader threat” from suspected Russia plague case

• by Teraya Smith

• October 7, 2026

FDA approves XFG-adapted COVID-19 vaccine

The 2026 to 2027 formulation aligns with FDA guidance on the preferred composition for COVID-19 vaccines beginning this fall.

• by Kathryn Wighton

• August 28, 2026

• 2 min

Risk models may improve lung cancer screening

Analysis found no single prediction model optimized screening eligibility, sensitivity, and efficiency across all racial and ethnic groups.

• by Olivia Anderson

• August 24, 2026

• 3 min

FDA updates PAH label with trial data

In adults diagnosed with pulmonary arterial hypertension within the previous year, adding sotatercept to background therapy reduced the risk of clinical worsening events by 76% compared with placebo.

• by Kathryn Wighton

• September 22, 2026

• 3 min